Top Qs
Timeline
Chat
Perspective

Syncona

British investment trust From Wikipedia, the free encyclopedia

Remove ads

Syncona (LSE: SYNC) is a large British closed-ended investment trust dedicated to life science investments. Co-founded as Syncona Partners in 2012 by current CEO Martin Murphy and the Wellcome Trust,[1] before merging with the Battle Against Cancer Investment Trust ('BACIT') in December 2016 and listing publicly,[2] the company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.[3] Its Chair is Melanie Gee.[4]

Quick facts Company type, Traded as ...
Remove ads

References

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.

Remove ads